[Edaily Reporter Kwon Oh Seok ] Global medical aesthetics device specialist Hironic Co.,Ltd(149980)announced on the 14th that it participated in the “2026 Korean Society of Aesthetic, Obesity, and Regenerative Medicine (KORA) Fall Academic Conference,” held at COEX in Seoul on the 11th, where it showcased its major medical devices and core technologies.

At this academic conference, Hironic Co.,Ltd focused on “MIGLOU”—which received product approval from the Ministry of Food and Drug Safety last July—and conducted exhibition and brand promotion activities. MIGLOU is a medical device equipped with 2.45 gigahertz (GHz) microwave energy and Focused Intensive Microwave (FIM) technology. The company designed its booth around the slogan “Focused Microwave, MIGLOU is WATTA” to actively promote MIGLOU’s proprietary technology and product features.
In addition to Miglow, the company also showcased its new product, “Synerget Pro”—which began full-scale distribution to hospitals and clinics last August—and its long-standing bestseller, “V-Lifting.” The Synerget Pro is a needle-free injector medical device that organically combines three technologies: Microjet, low-frequency stimulation based on electroporation (EP) tips, and plasma. The V-Lifting is a dual-energy platform that fuses high-intensity focused ultrasound (HIFU) and radiofrequency (RF), and is Hironic Co.,Ltd’s flagship product.
Celebrating its 20th anniversary this year, Hironic Co.,Ltd incorporated commemorative design elements throughout its booth to further highlight its brand identity and the competitiveness of its key product lineup. In addition to providing detailed introductions to the core technologies behind each product, the company focused on enhancing product credibility through on-site communication with medical professionals.
A Hironic Co.,Ltd representative stated, “The KORA 2026 academic conference was a valuable opportunity to showcase our technological capabilities, including Miglow, and to engage closely with healthcare professionals on-site,” adding, “We will continue to actively participate in major domestic and international academic conferences and medical device exhibitions to widely promote our technological excellence and further expand our engagement with the medical community.”